Dar Zavain — SEC Form 4 filings
SEC reporting owner CIK 1852075. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-04-03 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | 13 | — | — | 15 |
Form 4 filings — Dar Zavain
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 5,109 @ $0 | EDGAR |
| 2026-06-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 88,424 @ $0 | EDGAR |
| 2026-04-02 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 4,902 @ $0 | EDGAR |
| 2026-01-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 3,571 @ $0 | EDGAR |
| 2025-10-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,941 @ $0 | EDGAR |
| 2025-07-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,924 @ $0 | EDGAR |
| 2025-06-23 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 22,016 @ $0 · Grant/award (A): 44,031 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,745 @ $0 | EDGAR |
| 2025-01-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,907 @ $0 | EDGAR |
| 2024-10-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,229 @ $0 | EDGAR |
| 2024-07-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,843 @ $0 | EDGAR |
| 2024-06-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,467 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1852075 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →